# Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer

> **NCT00004177** · PHASE1,PHASE2 · COMPLETED · sponsor: **Garden State Cancer Center at the Center for Molecular Medicine and Immunology** · enrollment: 15 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** indium In 111 monoclonal antibody MN-14
- **RADIATION:** yttrium Y 90 monoclonal antibody MN-14

## Key facts

- **NCT ID:** NCT00004177
- **Lead sponsor:** Garden State Cancer Center at the Center for Molecular Medicine and Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** 2002-05
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2011-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004177, "Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*